Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

Form 8.3 - Vernalis Plc

8 Oct 2018 15:07

RNS Number : 3245D
Legal & General Investment Mgmnt Ld
08 October 2018
 

FORM 8.3

PUBLIC DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

 

Legal And General Investment Management Ltd.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

Legal And General Investment Management Ltd.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Vernalis Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

No

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

05 October 2018

 

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 

No

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

ORD GBP 0.01

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

7,606,378

 

1.44%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

 

 

7,606,378

 

1.44%

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

N/A

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

ORD GBP 0.01

 

 

Sale

 

2,900,000

 

GBP 0.0614

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

 

NO

 

 

 

Date of disclosure:

 

08 October 2018

Contact name:

 

Nadeem Tariq

Telephone number:

 

02920 35 5444

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETFKFDKQBDDNKK
Date   Source Headline
3rd May 20184:35 pmRNSPrice Monitoring Extension
27th Apr 20181:31 pmRNSForm 8.5 (EPT/RI)
20th Apr 20185:53 pmRNSHolding(s) in Company
20th Apr 20185:52 pmRNSHolding(s) in Company
20th Apr 20182:42 pmRNSForm 8.3 - Vernalis plc
20th Apr 201812:57 pmRNSHolding(s) in Company
20th Apr 201810:01 amRNSForm 8.3 - Vernalis Plc
20th Apr 201810:00 amRNSForm 8.3 - Vernalis PLC
18th Apr 20184:35 pmRNSPrice Monitoring Extension
17th Apr 20182:15 pmRNSForm 8.3 - Vernalis Plc
29th Mar 201810:08 amRNSPublic Opening Position Disclosure
29th Mar 20187:00 amRNSBlock Listing 6 Montly Return
28th Mar 20187:00 amRNSUnaudited Interim Results for 6 months to 31/12/17
22nd Mar 201810:47 amRNSForm 8.5 (EPT/RI)
21st Mar 20184:05 pmRNSRule 2.9 Announcement
21st Mar 20181:11 pmRNSForm 8.3 - Vernalis Plc
20th Mar 20183:10 pmRNSForm 8.3 - Vernalis Plc
20th Mar 20183:10 pmRNSForm 8.3 - Vernalis Plc
20th Mar 20183:08 pmRNSForm 8.3 - Vernalis Plc
20th Mar 20182:42 pmRNSForm 8.3 - Vernalis PLC
19th Mar 20181:41 pmRNSForm 8.3 - Vernalis Plc
16th Mar 20182:47 pmRNSForm 8.3 - Vernalis plc
16th Mar 20182:25 pmRNSForm 8.5 (EPT/RI)
16th Mar 20181:00 pmRNSForm 8.3 - Vernalis Plc
16th Mar 201810:08 amRNSForm 8.3 - Vernalis Plc
15th Mar 20183:14 pmRNSForm 8.3 - Vernalis Plc
15th Mar 20187:00 amRNSUpdate on Strategic Review and Formal Sale Process
2nd Mar 20184:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20184:35 pmRNSPrice Monitoring Extension
1st Mar 20184:52 pmRNSHolding(s) in Company
28th Feb 20187:00 amRNSVernalis plc Trading and Corporate Update
8th Feb 20184:35 pmRNSPrice Monitoring Extension
29th Dec 20177:00 amRNSTotal Voting Rights
27th Dec 20174:40 pmRNSSecond Price Monitoring Extn
27th Dec 20174:35 pmRNSPrice Monitoring Extension
14th Dec 20171:15 pmRNSVernalis Results of Annual General Meeting
14th Dec 20177:00 amRNSAGM Statement
13th Dec 20177:00 amRNSVernalis + Daiichi Sankyo Enter Collaboration
6th Dec 20177:00 amRNSVernalis and Servier Achieve Research Milestone
5th Dec 20174:40 pmRNSSecond Price Monitoring Extn
5th Dec 20174:35 pmRNSPrice Monitoring Extension
30th Nov 201712:34 pmRNSTotal Voting Rights
2nd Nov 20177:00 amRNSNotice of Annual Report and AGM
31st Oct 20177:00 amRNSTotal Voting Rights
29th Sep 20177:00 amRNSBlock listing Interim Review
12th Sep 20177:00 amRNSResults Announcement for the Year Ended 30/06/2017
7th Aug 20177:00 amRNSFDA Issues Complete Response Letter on CCP-08 NDA
18th Jul 20177:00 amRNSYear-End Trading Update and Notice of Results
30th Jun 20177:00 amRNSTotal Voting Rights
31st May 20177:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.